The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | BBG00QG40R88 | 55,466,425 | 3,069,531 | SH | SOLE | 3,069,531 | 0 | 0 | ||
89BIO INC | COM | 282559103 | BBG00QKDZ8J5 | 216,351,165 | 11,416,948 | SH | SOLE | 11,416,948 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | SPONSORED ADS | 00461U105 | BBG003LF0QR9 | 45,611,958 | 4,398,453 | SH | SOLE | 4,398,453 | 0 | 0 | ||
ACRIVON THERAPEUTICS INC | COM | 004890109 | BBG011RWR2Q4 | 62,344,184 | 4,810,508 | SH | SOLE | 4,810,508 | 0 | 0 | ||
ACUMEN PHARMACEUTICALS INC | COMMON STOCK | 00509G209 | BBG0058YJ317 | 46,997,418 | 9,770,773 | SH | SOLE | 9,770,773 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | BBG00WGHZFH4 | 141,727,291 | 8,263,982 | SH | SOLE | 8,263,982 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | BBG001J2LL66 | 48,225,310 | 4,691,178 | SH | SOLE | 4,691,178 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | BBG00QYLYBK4 | 32,074,895 | 3,773,517 | SH | SOLE | 3,773,517 | 0 | 0 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | BBG00FZQGXG3 | 20,164,843 | 3,009,678 | SH | SOLE | 3,009,678 | 0 | 0 | ||
ASCENDIS PHARMA A/S | COM | 04351P101 | BBG007R7VNC1 | 1,001,863,112 | 11,225,357 | SH | SOLE | 11,225,357 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | BBG00FQ7LXW1 | 71,164,508 | 6,416,998 | SH | SOLE | 6,416,998 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | CLASS A ORD SHS | 05464T104 | BBG00B6G7GL7 | 71,860,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BIOGEN INC | SPONSORED ADR | 09062X103 | BBG000C17X76 | 151,794,286 | 532,892 | SH | SOLE | 532,892 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | BBG00MS4Y0W9 | 17,805,058 | 3,525,754 | SH | SOLE | 3,525,754 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | BBG00HKBW045 | 15,372,011 | 1,400,001 | SH | SOLE | 1,400,001 | 0 | 0 | ||
COGENT COMMUNICATIONS HLDGS | COM | 19240Q201 | BBG007DHZQR7 | 75,967,180 | 6,416,147 | SH | SOLE | 6,416,147 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | COM | 207523101 | BBG00ZGYNJ49 | 7,899,833 | 6,991,003 | SH | SOLE | 6,991,003 | 0 | 0 | ||
CUREVAC N V | COM | N2451R105 | BBG00W9LXXJ4 | 127,602,851 | 12,245,955 | SH | SOLE | 12,245,955 | 0 | 0 | ||
CYTEK BIOSCIENCES INC | COM | 23285D109 | BBG00D36Q0Z7 | 105,022,537 | 12,297,721 | SH | SOLE | 12,297,721 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | BBG00V1KSN04 | 93,249,633 | 7,809,852 | SH | SOLE | 7,809,852 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | BBG00SNC49V8 | 18,718,755 | 2,971,231 | SH | SOLE | 2,971,231 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | BBG00WLPGWQ4 | 365,018,194 | 7,856,612 | SH | SOLE | 7,856,612 | 0 | 0 | ||
ELIEM THERAPEUTICS INC | ADS | 28658R106 | BBG00ZNKL0K6 | 36,822,377 | 13,150,849 | SH | SOLE | 13,150,849 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | BBG00CP3BDD4 | 43,319,511 | 2,122,465 | SH | SOLE | 2,122,465 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM | 30233G209 | BBG000F90JX5 | 29,323,402 | 3,370,506 | SH | SOLE | 3,370,506 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | CLASS A COM | 359616109 | BBG00DDY1RK9 | 38,312,023 | 11,609,704 | SH | SOLE | 11,609,704 | 0 | 0 | ||
GERON CORP | COM | 374163103 | BBG000GX1891 | 101,258,827 | 31,544,806 | SH | SOLE | 31,544,806 | 0 | 0 | ||
GH RESEARCH PLC | SPONSORED ADR | G3855L106 | BBG011BQC379 | 66,293,706 | 5,587,333 | SH | SOLE | 5,587,333 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | BBG00QHK2J87 | 59,218,200 | 5,963,565 | SH | SOLE | 5,963,565 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | BBG00PNR1BT2 | 8,653,125 | 937,500 | SH | SOLE | 937,500 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | BBG000C2JTB5 | 43,966,307 | 2,329,958 | SH | SOLE | 2,329,958 | 0 | 0 | ||
INHIBRX INC | SHS | 45720L107 | BBG00P80N9T9 | 100,046,387 | 3,853,867 | SH | SOLE | 3,853,867 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | BBG00VPNFSJ5 | 58,484,509 | 4,417,259 | SH | SOLE | 4,417,259 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | BBG00ZHSKH11 | 102,920,544 | 8,670,644 | SH | SOLE | 8,670,644 | 0 | 0 | ||
LEGEND BIOTECH CORP | COM | 52490G102 | BBG00TTGH5W4 | 432,452,724 | 6,264,707 | SH | SOLE | 6,264,707 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | BBG00ZXN1GN3 | 54,193,016 | 3,178,476 | SH | SOLE | 3,178,476 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES | ORDINARY SHARES | 63009R109 | BBG0019K7GX4 | 6,979,661 | 1,723,373 | SH | SOLE | 1,723,373 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORD SHS | N62509109 | BBG01BNNTQN4 | 107,010,000 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORD SHS | N62509117 | BBG01BNP2MK0 | 696,666 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | BBG00JXHS9G7 | 17,093,233 | 7,805,129 | SH | SOLE | 7,805,129 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | BBG012232618 | 72,699,651 | 8,131,952 | SH | SOLE | 8,131,952 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | BBG00C8083N4 | 31,927,440 | 1,762,000 | SH | SOLE | 1,762,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ601 | 93,598,345 | 5,676,067 | SH | SOLE | 5,676,067 | 0 | 0 | ||
RXSIGHT INC | COM | 78349D107 | BBG00THX1YN4 | 87,920,525 | 3,052,796 | SH | SOLE | 3,052,796 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E204 | BBG00JN4FXG8 | 17,953,739 | 3,426,286 | SH | SOLE | 3,426,286 | 0 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | BBG00NX995R3 | 7,092,852 | 2,333,175 | SH | SOLE | 2,333,175 | 0 | 0 | ||
TENAYA THERAPEUTICS INC | COM | 87990A106 | BBG00FPMK2S3 | 35,616,125 | 6,067,483 | SH | SOLE | 6,067,483 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | BBG00RCQD9D1 | 123,236,812 | 7,236,454 | SH | SOLE | 7,236,454 | 0 | 0 | ||
VAXCYTE INC | SPONSORED ADS | 92243G108 | BBG009PHHPL8 | 394,089,225 | 7,891,254 | SH | SOLE | 7,891,254 | 0 | 0 | ||
VERONA PHARMA PLC | COM | 925050106 | BBG00GD4KBL1 | 133,562,309 | 6,317,990 | SH | SOLE | 6,317,990 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H242Z5 | 47,769,035 | 2,007,946 | SH | SOLE | 2,007,946 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | BBG00NBJRDT6 | 70,294,039 | 22,748,880 | SH | SOLE | 22,748,880 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | COM | Y95308105 | BBG00B642V54 | 62,615,313 | 17,202,009 | SH | SOLE | 17,202,009 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | BBG00QXQ9XK4 | 18,741,887 | 6,144,881 | SH | SOLE | 6,144,881 | 0 | 0 |